Takeda Kenji

タケダケンジ | Takeda Kenji

Affiliation and department：

Research field (1)： Molecular biology

Research keywords (5)： RALT , CHK1 , Cytoplasmic Protein Quality Controls , negative regulator , 心筋細胞

Research theme for competitive and other funds (8)：

2021 - 2024 Molecular mechanism of complete statin intolerance in Japanese
2020 - 2022 MuleによるCHK1を介した心筋ストレス応答の制御機序の解明
2008 - 2009 Gene33/RALTは心筋の酸化ストレス障害に対する制御因子か?
2007 - 2008 Carddiac remodeling therapy due to induced expression by cardiac adiponectin
2005 - 2006 Therapeutic adaptation of cardiac expression of adiponectin

Show all

Papers (32)：

ｍore...

MISC (1)：

赤尾浩慶, 河合康幸, 竹田健史. From Bench To Bedside(第7回)スタチンのpharmacogenomics. Vascular medicine. 2007. 3. 2. 182-187

Patents (1)：

Lectures and oral presentations (20)：

Novel approach: Elucidating the intracellular clearance mechanism of toxic AGEs (TAGE) utilizing the artificial. CHK1 mutant d270KD as a substrate model.
(2023)
Toxic AGEs (TAGE) と健康
(第27回糖化ストレス研究会 2023)
糖代謝中間体グリセルアルデヒドが引き起こす骨芽細胞障害
(第23回日本抗加齢医学会総会 2023)
The HECT-type ubiquitin ligase Mule is involved in the kinase-inactive mutation-specific rapid degradation of Chk1 lacking its carboxyl terminus.
(The 43rd Annual Meeting of the Molecular Biology Society of Japan 2020)
迅速な細胞応答を観察するための蛋白質不安定化タグ
(平成29年度中部地区医療・バイオ系シーズ発表会 2017)

ｍore...

Education (1)：

Professional career (1)：

Work history (1)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page